MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Hospira Company Profile (NYSE:HSP)

Consensus Ratings for Hospira (NYSE:HSP) (?)
Ratings Breakdown: 1 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $90.00 (0.06% upside)

Analysts' Ratings History for Hospira (NYSE:HSP)
Show:
DateFirmActionRatingPrice TargetActions
5/13/2015Deutsche BankReiterated RatingBuy$90.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/5/2015Goldman SachsUpgradeSell -> Neutral$51.00 -> $68.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/7/2014JPMorgan Chase & Co.Reiterated RatingNeutral$55.00 -> $56.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/7/2014BarclaysReiterated RatingEqual Weight$47.00 -> $53.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/7/2014Bank of AmericaReiterated RatingNeutral$61.00 -> $62.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/7/2014Raymond JamesUpgradeUnderperform -> Market PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/29/2014CIMBInitiated Coverageadd$2.75View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/31/2014Citigroup Inc.Reiterated RatingSell$35.00 -> $41.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/11/2014Wells FargoInitiated CoverageMarket PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/2/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha